Atogepant

(Qulipta)

Atogepant

Drug updated on 11/15/2023

Dosage FormTablet (oral; 10 mg, 30 mg, 60 mg)
Drug ClassCalcitonin gene-related peptide receptor antagonists
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the preventive treatment of migraine in adults.